NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 184 filers reported holding NEVRO CORP in Q3 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $910,000 | -7.9% | 11,400 | 0.0% | 0.12% | -19.0% |
Q1 2018 | $988,000 | +25.5% | 11,400 | 0.0% | 0.15% | +28.6% |
Q4 2017 | $787,000 | -24.0% | 11,400 | 0.0% | 0.12% | -29.2% |
Q3 2017 | $1,036,000 | +22.0% | 11,400 | 0.0% | 0.17% | +33.3% |
Q2 2017 | $849,000 | -20.5% | 11,400 | 0.0% | 0.13% | -37.0% |
Q1 2017 | $1,068,000 | +29.0% | 11,400 | 0.0% | 0.20% | +22.0% |
Q4 2016 | $828,000 | -30.4% | 11,400 | 0.0% | 0.16% | -27.1% |
Q3 2016 | $1,190,000 | – | 11,400 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Engaged Capital LLC | 1,885,956 | $15,879,750 | 2.72% |
Kent Lake Capital LLC | 639,775 | $5,386,906 | 2.43% |
Wellington Wealth Strategies, LLC. | 71 | $538,662 | 2.26% |
Palo Alto Investors LP | 750,371 | $6,318,124 | 0.73% |
BRAIDWELL LP | 1,698,768 | $14,303,627 | 0.45% |
ArrowMark Colorado Holdings LLC | 4,289,108 | $36,114,289 | 0.43% |
ARMISTICE CAPITAL, LLC | 3,672,000 | $30,918,240 | 0.39% |
Rock Springs Capital Management LP | 1,381,500 | $11,632,230 | 0.35% |
Eversept Partners, LP | 499,395 | $4,204,906 | 0.29% |
Olympiad Research LP | 25,046 | $210,887 | 0.16% |